Oral Ketorolac for Arthroscopic Rotator Cuff Repair
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent
to the standard of care pain protocol for postoperative pain control following
arthroscopic rotator cuff repair.
2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the
standard of care pain protocol will reduce postoperative opioid consumption following
arthroscopic rotator cuff repair.